These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24797582)

  • 1. The maturation of antibody technology for the HIV epidemic.
    Winnall WR; Beasley MD; Center RJ; Parsons MS; Kiefel BR; Kent SJ
    Immunol Cell Biol; 2014 Aug; 92(7):570-7. PubMed ID: 24797582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.
    Boesch AW; Alter G; Ackerman ME
    Curr Opin HIV AIDS; 2015 May; 10(3):160-9. PubMed ID: 25700208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
    Fournier P; Schirrmacher V
    BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bispecific Antibodies Against HIV.
    Montefiori DC
    Cell; 2016 Jun; 165(7):1563-1564. PubMed ID: 27315470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell abnormalities and impact on antibody response in HIV infection.
    Noto A; Pantaleo G
    Curr Opin HIV AIDS; 2017 May; 12(3):203-208. PubMed ID: 28422784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection.
    Ferrari G; Haynes BF; Koenig S; Nordstrom JL; Margolis DM; Tomaras GD
    Nat Rev Drug Discov; 2016 Dec; 15(12):823-834. PubMed ID: 27725635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.
    Zhang Z; Li S; Gu Y; Xia N
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
    Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
    J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the complement system in antibody-mediated post-exposure protection against human immunodeficiency virus type 1.
    Gauduin MC; Weir R; Fung MS; Koup RA
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):205-11. PubMed ID: 9491910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical engineering of cell surfaces to generate virus resistance.
    Xie J; Sok D; Wu NC; Zheng T; Zhang W; Burton DR; Lerner RA
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4655-4660. PubMed ID: 28396429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus antibodies and the vaccine problem.
    Chiodi F; Weiss RA
    J Intern Med; 2014 May; 275(5):444-55. PubMed ID: 24581142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.
    Chamow SM; Zhang D; Tan XY; Mhatre SM; Marsters SA; Peers DH; Byrn RA; Ashkenazi A; Junghans RP
    J Hematother; 1995 Oct; 4(5):439-46. PubMed ID: 8581382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional recombinant fusion proteins for rapid detection of antibodies to both HIV-1 and HIV-2 in whole blood.
    Gupta A; Chaudhary VK
    BMC Biotechnol; 2006 Sep; 6():39. PubMed ID: 16995928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
    Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
    J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.
    Kramski M; Lichtfuss GF; Navis M; Isitman G; Wren L; Rawlin G; Center RJ; Jaworowski A; Kent SJ; Purcell DF
    Eur J Immunol; 2012 Oct; 42(10):2771-81. PubMed ID: 22730083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1.
    Forthal DN; Landucci G; Phan TB; Becerra J
    J Virol; 2005 Feb; 79(4):2042-9. PubMed ID: 15681406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.